Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ABVX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – EUR
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Abivax SA

ABVX
Current price
8.27 USD +0.06 USD (+0.73%)
Last closed 7.06 EUR
ISIN FR0012333284
Sector Healthcare
Industry Biotechnology
Exchange PA
Capitalization 450 717 375 EUR
Yield for 12 month -44.02 %
1Y
3Y
5Y
10Y
15Y
ABVX
21.11.2021 - 28.11.2021

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France. Address: 7-11 boulevard Haussmann, Paris, France, 75009

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19.19 EUR

P/E Ratio

Dividend Yield

Financials ABVX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+10 821 498 EUR

Last Year

+4 633 631 EUR

Current Quarter

Last Quarter

+4 016 950 EUR

Current Year

+10 821 498 EUR

Last Year

+4 505 281 EUR

Current Quarter

Last Quarter

+4 016 950 EUR
EBITDA -174 870 679 EUR
Operating Margin TTM -4 865.98 %
Price to Earnings
Return On Assets TTM -48.60 %
PEG Ratio
Return On Equity TTM -196.12 %
Wall Street Target Price 19.19 EUR
Revenue TTM 10 616 941 EUR
Book Value -0.10 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -17.40 %
Dividend Yield
Gross Profit TTM 10 616 941 EUR
Earnings per share -2.96 EUR
Diluted Eps TTM -2.96 EUR
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 147.75
Price Sales TTM 42.45
Enterprise Value EBITDA -16.47
Price Book MRQ 8.53

Technical Indicators ABVX

For 52 Weeks

4.52 EUR 13.00 EUR
50 Day MA 5.98 EUR
Shares Short Prior Month
200 Day MA 6.93 EUR
Short Ratio
Shares Short
Short Percent